Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments

Condensed Consolidated Balance Sheets

v3.22.2.2
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Jun. 30, 2022
Dec. 31, 2021
Current assets:    
Cash and cash equivalents $ 36,290 $ 13,148
Short term cash deposits   30,151
Restricted deposit 23 13
Trade receivables 9 270
Other accounts receivable and prepaid expenses 594 424
Inventories 1,356 1,081
Total current assets 38,272 45,087
Non-current assets:    
Restricted deposit 189 213
Operating lease right-of-use assets 2,792 2,953
Property and equipment, net 2,925 2,728
Intangible assets, net 235 243
Total non-current assets 6,141 6,137
Total assets 44,413 51,224
Accounts payable:    
Trade payables 760 1,034
Operating lease liabilities 477 519
Deferred revenues 32
Accrued liabilities and other 1,124 1,429
Total current liabilities 2,361 3,014
Non-current liabilities:    
Operating lease liabilities 2,547 3,089
Total non-current liabilities 2,547 3,089
Total liabilities 4,908 6,103
Commitments and contingencies
Shareholders’ Equity:    
Ordinary shares, NIS 1.5 par value - authorized: 30,000,000 ordinary shares as of June 30, 2022 and December 31, 2021; issued and outstanding: 11,086,481 and 10,772,024 ordinary shares as of June 30, 2022 and December 31, 2021, respectively 4,831 4,664
Additional paid in capital and warrants 116,585 114,223
Currency translation differences (969) (969)
Accumulated deficit (80,942) (72,797)
Total shareholders’ equity 39,505 45,121
Total liabilities and shareholders’ equity $ 44,413 $ 51,224